Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira and MTX with Steroid Reduction Strategies in Rheumatoid Arthritis
NCT00233558Phase 4Terminated
- Sponsor
- Abbott Laboratories
- Start
- Jun 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of Trudexa in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Jun 2005; status: terminated.
02
Drugs
Trudexa
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00233558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233558.